| Dr Gigi Girgis, MD | |
|
20 Hope Ave, Suite 203, Waltham, MA 02453-2721 | |
| (781) 647-3550 | |
| (781) 899-8845 |
| Full Name | Dr Gigi Girgis |
|---|---|
| Gender | Female |
| Speciality | Neurology |
| Experience | 44 Years |
| Location | 20 Hope Ave, Waltham, Massachusetts |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053387316 | NPI | - | NPPES |
| 3000494 | Medicaid | MA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084N0400X | Psychiatry & Neurology - Neurology | 50799 (Massachusetts) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Newton-wellesley Hospital | Newton, MA | Hospital |
| Massachusetts General Hospital | Boston, MA | Hospital |
| Brigham And Women's Hospital | Boston, MA | Hospital |
| Cape Cod Healthcare | Hyannis, MA | Hospital |
| Entity Name | The Mclean Hospital Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114979580 PECOS PAC ID: 9436040961 Enrollment ID: O20040323001228 |
News Archive
Rep. Jan Schakowsky visited Wockhardt's Morton Grove facility with a goal in mind: strengthening efforts to revitalize American manufacturing.
Actavis plc today confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration seeking approval to market Methylphenidate Hydrochloride for Extended-release Oral Suspension, 5 mg/mL. Actavis' ANDA product is a generic version of Pfizer and Tris Pharma's Quillivant XR®, which is a central nervous system stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder.
Health Robotics today announced that it has signed an exclusive five-year strategic partnership with Device Technologies Australia Pty Ltd. for its revolutionary CytoCare(TM) Robot. This strategic agreement enables Device Technologies Australia to achieve its goal of safely, accurately and cost-effectively automating the preparation of Oncology I.V. Admixtures to complement its other market-leading Oncology and Surgery Robotic solutions.
Particle Sciences, a leading drug delivery CDMO, has received a Notice of Allowance for composition and use of the technology incorporated into its SATx™ platform...
More than one billion people all over the world suffer from tropical diseases which are mostly unknown to the wider public and have also been neglected economically. In a joint effort with four other European foundations, the Volkswagen Foundation has opened a second round of funding for African scientists conducting research on these neglected diseases.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Gigi Girgis, MD 20 Hope Ave, Suite 203, Waltham, MA 02453-2721 Ph: (781) 647-3550 | Dr Gigi Girgis, MD 20 Hope Ave, Suite 203, Waltham, MA 02453-2721 Ph: (781) 647-3550 |
News Archive
Rep. Jan Schakowsky visited Wockhardt's Morton Grove facility with a goal in mind: strengthening efforts to revitalize American manufacturing.
Actavis plc today confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration seeking approval to market Methylphenidate Hydrochloride for Extended-release Oral Suspension, 5 mg/mL. Actavis' ANDA product is a generic version of Pfizer and Tris Pharma's Quillivant XR®, which is a central nervous system stimulant indicated for the treatment of Attention Deficit Hyperactivity Disorder.
Health Robotics today announced that it has signed an exclusive five-year strategic partnership with Device Technologies Australia Pty Ltd. for its revolutionary CytoCare(TM) Robot. This strategic agreement enables Device Technologies Australia to achieve its goal of safely, accurately and cost-effectively automating the preparation of Oncology I.V. Admixtures to complement its other market-leading Oncology and Surgery Robotic solutions.
Particle Sciences, a leading drug delivery CDMO, has received a Notice of Allowance for composition and use of the technology incorporated into its SATx™ platform...
More than one billion people all over the world suffer from tropical diseases which are mostly unknown to the wider public and have also been neglected economically. In a joint effort with four other European foundations, the Volkswagen Foundation has opened a second round of funding for African scientists conducting research on these neglected diseases.
› Verified 5 days ago
Dr. Robert R Wolff, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 9 Hope Ave, Waltham, MA 02453 Phone: 617-355-2063 | |
Robert Long Kelley, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 20 Hope Ave Suite 201, Waltham, MA 20453 Phone: 781-891-4909 | |
Shreyansh Shah, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: Wac-7-721-j, 15 Parkman Street, Massachusetts Genral Hospital, Waltham, MA 02453 Phone: 281-827-5041 | |
Pearl Alweny, NP Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 273 Ridge Ln Apt 308, Waltham, MA 02452 Phone: 857-316-8020 | |
Tanya Yanovsky, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 20 Hope Ave, Suite G05, Waltham, MA 02453 Phone: 781-893-8762 Fax: 781-899-6386 | |
Brian J Freeman, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 890 Winter St, Ste.320, Waltham, MA 02451 Phone: 781-622-5334 |